SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-165303
Filing Date
2022-06-01
Accepted
2022-06-01 17:00:35
Documents
12
Period of Report
2022-05-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d310834d8k.htm   iXBRL 8-K 21399
  Complete submission text file 0001193125-22-165303.txt   142810

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA igms-20220525.xsd EX-101.SCH 2841
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE igms-20220525_lab.xml EX-101.LAB 17978
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE igms-20220525_pre.xml EX-101.PRE 11248
6 EXTRACTED XBRL INSTANCE DOCUMENT d310834d8k_htm.xml XML 3351
Mailing Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043
Business Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043 650-965-7873
IGM Biosciences, Inc. (Filer) CIK: 0001496323 (see all company filings)

IRS No.: 770349194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39045 | Film No.: 22988137
SIC: 2834 Pharmaceutical Preparations